Home » Newsletters » BioWorld

BioWorld

Jan. 11, 2001

View Archived Issues

Pharmos Starts Phase III Study Of Dexanabinol In Brain Injury

SciClone Begins Pivotal U.S. Trial Of Zadaxin In Hepatitis C Patients

Other News To Note

Clarification

Collateral, Berlex Plan Pivotal Angiogenic Gene Therapy Trial

Switching On Apaf-1, A Protein Inactivated In Tumors, To Revive Effectiveness Of Chemotherapy

Millennium Delivering To Bayer 'First Genomics-Derived' Target

Nexell Agrees To Sell Up To $25M In Shares To Acqua Wellington